Epstein-Barr virus (EBV) is a ubiquitous herpes virus that infects the majority of the
population worldwide. The virus can establish a lifelong latent infection in host B …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALF, acute liver failure; ALT, alanine aminotransferase; AMA …

Opinion statement In the treatment of Epstein-Barr virus (EBV)-related lymphomas, there are
few therapies specifically targeted against the latent virus within these tumors; in most cases …

Long term outcomes after liver transplantation are major determinants of quality of life and of
the value of this heroic treatment. As short term outcomes are excellent, our community is …

Autoimmune hepatitis can recur or appear de novo after liver transplantation, and it can
result in hepatic fibrosis, graft loss, and re-transplantation. The goals of this review are to …

Epstein-Barr virus (EBV)-associated postallogeneic stem cell transplantation (SCT)
lymphoproliferative disorder (PTLD) is often life threatening. The risk of EBV reactivation is …

Graft-versus-host disease (GVHD) remains a major cause of morbidity and mortality after
allogeneic hematopoietic stem cell transplantation (HSCT). Measures developed that have …

Controlled trials of m TOR inhibitors in children following solid organ transplantation are
scarce, although evidence from prospective single‐arm studies is growing. Everolimus with …

Posttransplant considerations in autoimmune liver disease: Recurrence of disease and <fi>de
novo</fi> Page 1 130 | Clin Liver Dis. 2022;20:130–135. wileyonlinelibrary.com/journal/cld …

The field of solid organ transplantation has grown enormously since 1983, when the
widespread availability of effective immunosuppression made what had been surgically …